- Conditions
- Type1diabetes
- Interventions
- BKR-017
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 20 Years to 80 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Mar 30, 2026 · Synced May 21, 2026, 7:38 PM EDT